Abstract
Introduction
Enterococcus faecium and E. faecalis are Gram-positive commensal bacteria inhabiting the present in broth microdilution assays (19) . In this study, we identified molecular factors that alter this phenotype, with the ultimate aim to exploit synergism between vancomycin and 79 chlorhexidine.
81
Here, we investigated three models we previously proposed (19) to explain chlorhexidine- 
95

Materials and Methods
97
Bacterial strains and growth conditions. Bacterial strains used in this study are shown in 98 Table 1 . E. faecium and E. faecalis were cultured at 37°C on brain heart infusion (BHI) agar or 99 in broth without agitation unless otherwise stated. Escherichia coli was cultured at 37°C in 100 lysogeny broth (LB) broth with shaking at 225 rpm or on LB with 1.5% agar unless otherwise 101 stated. The chlorhexidine product used for all experiments was Hibiclens (4% wt/vol 102 chlorhexidine gluconate with 4% isopropyl alcohol). We refer to Hibiclens as H-CHG in this 103 study. Antibiotics were added at the following concentrations: vancomycin, 50 μg/ml for E. faecium, and chloramphenicol, 15 μg/ml for E. coli and E. faecium. Routine molecular biology techniques. E. faecium genomic DNA (gDNA) was isolated using Overnight cultures of E. faecium or E. faecalis were diluted to OD 600 of 0.01 in fresh BHI, and 5 126 μl of the diluted culture was used to inoculate the wells of the plate. The OD 600 of the cultures 
143
After several unsuccessful attempts to generate unmarked deletions of pbpA and pbp5 genes in 144 E. faecium 1,231,410 (E. faecium 410), we introduced a tetracycline resistance marker (tetL) 145 between the flanking upstream and downstream arms of the deletion constructs to select for 146 deletion mutants. Briefly, tetL was amplified from pLT06-tet using primers tetL For and Rev. The 147 deletion constructs were linearized via PCR using Phusion DNA polymerase (Fisher) and 148 primers pbpA/5-linear For and Rev (Table S1 ). The linearized PCR products were 149 dephosphorylated using Shrimp Alkaline phosphatase (New England Biolabs) per the 150 manufacturer's instructions and then ligated with tetL to generate the deletion constructs PB408 151 and PB409. The deletion construct was propagated in EC1000 and sequenced using Sanger 152 sequencing prior to transformation into E. faecium 410.
154
Complementation of ddcP deletion. The ddcP gene was restored to the chromosome of the 155 E. faecium 410 ddcP deletion mutant. The ddcP gene and ~1 kb regions up-and downstream were amplified from E. faecium 410 wild-type gDNA, and the amplicon was digested and inserted into pHA101. The knock-in plasmid construct (pMI101) was transformed into the ddcP deletion mutant by electroporation. The temperature shifting and counter-selection protocol was followed as described previously (22). The chromosomal integration of the gene was confirmed by Sanger sequencing.
Growth kinetics of E. faecium in the presence of H-CHG and vancomycin. Overnight cultures of E. faecium were diluted to an OD 600 of 0.01 in fresh, pre-warmed BHI and incubated at 37°C with shaking at 100 rpm. The cultures were grown until OD 600 reached 0.5 to 0.6.
165
Twenty-five milliliters of the culture were added to equal amounts of pre-warmed BHI containing 166 vancomycin (50 μg/ml) and/or H-CHG (4.9 μg/ml), or only BHI (control). OD 600 values were monitored for 6 h, and an OD 600 reading was taken at the 24 h time point. The growth curves 168 were repeated independently three times. For assessing synergy between vancomycin and glycine, the same experimental design was used, except that H-CHG was replaced with 0.2 M glycine.
Isolation of E. faecium 1,231,410 synergy escaper mutant. An E. faecium 410 wild-type 173 culture treated with vancomycin and H-CHG was incubated for 24 h, when turbidity was 174 observed. The recovered culture was used as an inoculum for a second growth curve experiment with vancomycin and H-CHG. OD 600 values were monitored for 6 h, and at the end of 6 h, the cultures were cryopreserved at -80°C. The stocked populations were struck on BHI agar, and the synergy MIC was determined for well-isolated colonies using the broth 178 microdilution assay described above. Colonies with elevated synergy MIC as compared to the 179 parental E. faecium 410 strain were passaged three times in BHI broth and the synergy MICs determined again. A strain with a stably elevated synergy MIC was isolated; this strain is referred to as SE101. (Table 3 ). E. faecium 410 was selected because 241 we observed the strongest synergism phenotype with this strain (Table 2 ). Addition of D-lactate 242 to BHI broth lacking H-CHG resulted in a 4-fold increase in vancomycin MIC (Table 3) ,
243
demonstrating that excess D-lactate does in fact result in reduced vancomycin susceptibility.
244
However, and counter to our expectations, in the presence of both D-lactate and H-CHG, the H-
245
CHG-induced vancomycin resensitization phenotype was enhanced (Table 3) . This result (Table 3) . 
283
To determine whether Pbps contribute to vancomycin-chlorhexidine synergism against VRE
284
(Model 1), we deleted each of these genes in E. faecium 410 (Table 1) . We utilized growth curves to assess phenotypes of the deletion mutants in the presence and absence of vancomycin and H-CHG. For these experiments, vancomycin (50 μg/ml) and H-CHG (4.9 μg/ml) 287 were added to exponentially growing E. faecium cultures; a no-drug control was also performed.
288
As shown in Fig. 1A , the OD 600 of E. faecium 410 wild-type cultures decreased after addition of 289 vancomycin and H-CHG, consistent with cell lysis. After 24 h, the cultures treated with 290 vancomycin and H-CHG were visibly turbid, indicating that E. faecium can recover from the 291 effects of the antimicrobials in this experimental condition.
293
A ΔddcP mutant had a different phenotype from the wild-type strain in this assay (Fig. 1B) . After 294 treatment with vancomycin and H-CHG, the OD 600 values for the ddcP deletion mutant did not 295 decrease; rather, a bacteriostatic effect was observed. We conclude that deletion of ddcP 296 results in a partial loss of synergism between vancomycin and H-CHG. The difference in the
297
OD 600 values was statistically significant between the wild-type and the ΔddcP mutant for all 298 time points post-H-CHG and vancomycin addition (P-value < 0.05, one-tailed Student's t test).
299
The ΔddcP mutant was complemented by restoration of the ddcP gene in cis. The growth 300 phenotype of the complemented strain in the presence of vancomycin and H-CHG was similar 301 to the wild-type (Fig. 1C) . No statistically significant differences in growth were observed 302 between the wild-type and the ddcP complemented strain in the presence of vancomycin and H-303 CHG.
305
The growth phenotypes of the ΔpbpF, ΔponA, ΔpbpZ, ΔpbpA, Δpbp5, ΔddcY, Δldt fm , and ΔvanY 306 deletion mutants were comparable to the parental strain (Fig. S1A-L) with one exception. In the 307 absence of the pbpB transpeptidase (Fig. S1H) , the cultures did not recover from the effect of pronounced effect observed at the 24 h time point (Fig. 2A) . However, this lytic effect was not 316 observed for the ΔddcP mutant (P-value < 0.05, assessed by one-tailed Student's t-test) (Fig.   317   2B) . contributed to vancomycin-chlorhexidine synergism against VRE, which is a component of our (Fig. S1C) . Moreover, deletion of ddcP in a ΔvanY background did not further enhance the 329 phenotype of a ΔddcP mutant (Fig. S2E) .
331
E. faecium 1,231,410 can escape from vancomycin-chlorhexidine synergy. We observed 332 the growth kinetics of E. faecium 410 cultures exposed to no, either, or both 50 μg/ml 333 vancomycin and 4.9 μg/ml H-CHG over a two-day growth curve experiment. As shown in Fig.   334 3A, cultures exposed to vancomycin were growth-inhibited for the first 2.5 h after exposure, and 335 after 2.5 h, OD 600 began to increase, consistent with the induction of vancomycin resistance genes and synthesis of modified cell walls, as previously observed (49, 50). The cultures exposed to H-CHG were also temporarily growth-inhibited. Consistent with the experiments shown in Fig. 1A , the OD 600 of cultures exposed to both vancomycin and H-CHG declined, 339 consistent with cell lysis, and after 24 h, the cultures recovered.
341
The next day, the recovered culture (from the vancomycin + H-CHG growth curve) was used as 342 an inoculum to repeat the growth curve experiment (Fig. 3B) . Interestingly, the growth inhibition 343 phenotypes observed for the first growth curve experiment were not observed in this second that the synergism phenotype is altered in this strain (Fig. 4A and B) . SE101 was initially were observed for SE101 compared to the wild-type for time points 3 h after addition of 355 vancomycin and H-CHG (P-value < 0.05 using one-tailed Student's t test).
357
Utilizing whole genome sequencing, we identified a mutation conferring a S199L substitution in 358 PstB (EFTG_01173) in SE101. As a result of this substitution, the protein is predicted to fold into 359 a beta-strand instead of a coil (51). The pst (phosphate-specific transport) operon has been well 360 characterized in E. coli and consists of pstSCAB and phoU (a regulator). In phosphate-361 starvation conditions, inorganic phosphate (Pi) binds PstS and is released into the cytoplasm by 362 the inner membrane channel formed by PstA-PstC. PstB energizes this channel by hydrolyzing 363 ATP (52). We quantified the levels of intracellular inorganic phosphate (Pi) in the wild-type strain and in SE101. However, the levels were not significantly different for any time point assayed (Fig. S2) .
pst transport system (EFTG_01170-74) in SE101 and in the E. faecium 410 wild-type. The 369 growth observed in the presence of vancomycin and H-CHG for the SE101Δpst deletion mutant 370 was significantly different as compared to SE101 ( Fig. 4B and D ; P-value < 0.05 using one-371 tailed Student's t test). Specifically, unlike SE101, the OD 600 values did not increase for the that the pstB mutation in SE101 resulted in a gain of function; however, the exact mechanism(s) for this is unclear. 
402
Growth analyses of the E. faecium pbp deletion mutants provide support for Model 1. To our 403 knowledge, this is the first study to report successful deletion of all pbp genes in E. faecium.
404
Upon ddcP deletion, which is predicted to result in increased availability of pentapeptide 
790
The levels (pmoles) were normalized using CFU count. Standard deviation was calculated from 791 n=5 independent experiments and significance value was calculated using one-tailed Student's t 792 test. Time points: 1, OD 600 0.4-0.5; 2, OD 600 0.6-0.7; 3, OD 600 0.7-0.8; 4, OD 600 0.8-0.9; OD 600 793 1.0-1.5.
794
795 Table S1 . List of primers used in the study.
796
